NP
NVO

NorthRock Partners’s Novo Nordisk NVO Stock Holding History

NorthRock Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-200
Closed -$16.2K – 370
2023
Q2 		$16.2K Buy
+200
New +$16.3K ﹤0.01% 311

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

NorthRock Partners's NVO Position: Q1 2026 in Review

NorthRock Partners increased its Novo Nordisk (NVO) stake by 14% in Q1 2026, buying an estimated $39.7K and bringing the position to 7,026 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #568.

NorthRock Partners first reported a position in NVO in Q3 2023 and has held it in 7 quarters since. The position peaked at $336K in Q2 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • NorthRock Partners held 7,026 shares of Novo Nordisk worth $258K as of Q1 2026.
  • NorthRock Partners bought 838 Novo Nordisk shares in Q1 2026, an estimated $39.7K.
  • Novo Nordisk made up ﹤0.01% of NorthRock Partners's portfolio in Q1 2026, its #568 holding.
  • NorthRock Partners first reported a position in Novo Nordisk in Q3 2023 and has held it in 7 quarters since.
  • NorthRock Partners's Novo Nordisk position peaked at $336K in Q2 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.